Steven Weisser is a Senior Scientist in the Biopharmaceutical Development group at GlaxoSmithKline, where he works on downstream processing of therapeutic proteins. In this role, he is responsible for developing and characterizing purification processes and transferring them from the lab scale to manufacturing facilities for GMP production of a biopharmaceutical product.
Prior to joining GSK, Steven worked in the process development group at ImClone Systems Incorporated, where he developed and transferred purification processes for early-phase and commercially approved monoclonal antibodies.
Steven received his B.S. in Biochemistry from Lehigh University.